← Leaderboards
Jeffrey A Drebin
Washington University
$1,526,880
Attributed
$1,526,880
Total exposure
2
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$1,526,880 · 2
By mechanism
R01$1,090,080 · 1
R29$436,800 · 1
Top collaborators
No co-investigators on record.
Most similar at Washington University
Same institution · by research overlap
- John Morris$91,785,862
- Robert J Gropler$22,166,148
- Joel Synes Perlmutter$37,740,662
- Randall J Bateman$192,965,895
- Timothy J Eberlein$71,591,509
Others in their field
Top investigators on “Cell Growth Regulation”
- Peter O Kohler · Oregon Health And Science University$38,512,009
- Cornelia M Ulrich · Fred Hutchinson Cancer Research Center$32,526,205
- John Blenis · Harvard University (Medical School)$31,731,877
- Henry Shelton Earp · Univ Of North Carolina Chapel Hill$29,665,070
- Bert W O'Malley · Baylor College Of Medicine$29,065,355
- Kevin Struhl · Harvard University (Medical School)$27,879,324
Research focus
Cell Growth RegulationApoptosisNeoplasm /Cancer GeneticsGene ExpressionCell CycleImmunocytochemistryLaboratory MouseOligonucleotidesOncogenesPancreas NeoplasmsBiological Signal TransductionGenetic RegulationAntisense Nucleic AcidCarcinogenesisHuman TissueMutantTissue /Cell CultureTransfectionNeoplastic CellNeoplastic GrowthAntineoplasticsTumor Suppressor GenesAthymic MouseCadherins
Grant awards (8)
Therapeutic Targeting of Beta-Catenin in Colon Cancer$265,940
R01 · FY2006 · CA · contact PI
Therapeutic Targeting of Beta-Catenin in Colon Cancer$279,460
R01 · FY2004 · CA
Therapeutic Targeting of Beta-Catenin in Colon Cancer$272,340
R01 · FY2004 · CA
Therapeutic Targeting of Beta-Catenin in Colon Cancer$272,340
R01 · FY2003 · CA
HER2/NEU OVEREXPRESSION AND PANCREATIC CANCER$109,200
R29 · FY2003 · CA
HER2/NEU OVEREXPRESSION AND PANCREATIC CANCER$109,200
R29 · FY2002 · CA
HER2/NEU OVEREXPRESSION AND PANCREATIC CANCER$109,200
R29 · FY2001 · CA
HER2/NEU OVEREXPRESSION AND PANCREATIC CANCER$109,200
R29 · FY2000 · CA